Evidence map›Paper›PMID 41210885›Full record

ArticleFrontiers in medicine2025

Expression and significance of PIBF combined with Galectin-1 in cervical precancerous lesions.

Hong Wang

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Hong WangDepartment of Gynecology, Huai'an First People's Hospital, The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to discuss the significance of PIBF and Galectin-1 in cervical dysplasia tissue. Methods: The expression of PIBF and Galectin-1 in precancerous tissues of cervical cancer was determined by the immunohistochemical method and ELISA method, and their clinical significance was analyzed. Results: PIBF and Galectin-1 levels in cervicitis and CIN1 tissues showed no statistically significant difference; the levels of PIBF and Galectin-1 in CIN2 and CIN3 tissues were higher than those in cervicitis and CIN1, and the differences were statistically significant when compared with other groups in the CIN3 group. Conclusion: Compared with the normal cervical lesion tissue, the levels of PIBF and Galectin-1 in the precervical lesion tissue were significantly increased, suggesting that their elevated levels are significantly associated with the progression of cervical intraepithelial neoplasia.

Indexed as

cervical intraepithelial neoplasiaGalectin-1immunohistochemistryPIBFprecancerous lesion

Identifiers

PMID41210885
PMCPMC12588945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.